GB600658A - Hormone extracts - Google Patents

Hormone extracts

Info

Publication number
GB600658A
GB600658A GB11361/44A GB1136144A GB600658A GB 600658 A GB600658 A GB 600658A GB 11361/44 A GB11361/44 A GB 11361/44A GB 1136144 A GB1136144 A GB 1136144A GB 600658 A GB600658 A GB 600658A
Authority
GB
United Kingdom
Prior art keywords
urine
substance
pyridine
aqueous
conditions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB11361/44A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Canada Inc
Original Assignee
Ayerst Mckenna and Harrison Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayerst Mckenna and Harrison Inc filed Critical Ayerst Mckenna and Harrison Inc
Publication of GB600658A publication Critical patent/GB600658A/en
Expired legal-status Critical Current

Links

Abstract

A water-soluble oestrogenically active product effective upon oral administration is obtained by treating unhydrolysed urine of a pregnant mare or stallion with an adsorbent under weakly alkaline or neutral conditions to form an absorbate containing the oestrogenic substance, eluting the resulting adsorbate with an organic nitrogen-containing base with or without water, or with a mixture of chloroform and methyl alcohol under neutral or slightly alkaline conditions to form an extract of the substance, and recovering an aqueous concentrate containing the substance from the extract under neutral or slightly alkaline conditions. Suitable adsorbents are charcoal, calcium triphosphate and Fullers earth. Suitable organic bases are pyridine, aniline, morpholine, quinoline, monoethylamine, n-butylamine, or n-amylamine. According to an example, urine of pregnant mares, preserved by the addition of an alcohol-chloroform mixture, is treated with three successive portions of activated charcoal, the combined charcoal portions are mixed with successive portions of aqueous pyridine, the resulting pyridine extracts are combined and concentrated in vacuo at 40-50 degrees C., and water is added to the concentrate which is then washed successively with benzene and ether, the resulting aqueous concentrate containing the oestrogenically active hormones. A phosphate buffer of pH 7.5 may be added to ensure that the necessary pH conditions are maintained. The procedure of this example may be used in the treatment of stallions' urine, in the use of the other adsorbents or in the use of the other eluting solvents. The aqueous concentrates may be evaporated in vacuo to produce a dry powder.
GB11361/44A 1943-08-20 1944-06-14 Hormone extracts Expired GB600658A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA600658X 1943-08-20

Publications (1)

Publication Number Publication Date
GB600658A true GB600658A (en) 1948-04-15

Family

ID=4171908

Family Applications (1)

Application Number Title Priority Date Filing Date
GB11361/44A Expired GB600658A (en) 1943-08-20 1944-06-14 Hormone extracts

Country Status (1)

Country Link
GB (1) GB600658A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461809B2 (en) 2006-01-13 2013-06-11 Enecsys Limited Power conditioning unit
US8674668B2 (en) 2010-06-07 2014-03-18 Enecsys Limited Solar photovoltaic systems

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461809B2 (en) 2006-01-13 2013-06-11 Enecsys Limited Power conditioning unit
US8674668B2 (en) 2010-06-07 2014-03-18 Enecsys Limited Solar photovoltaic systems

Similar Documents

Publication Publication Date Title
DE3271829D1 (en) An allergen dry powder composition and process for its preparation
US2429398A (en) Hormone extracts
GB600658A (en) Hormone extracts
Hall et al. The role of the adrenals in the production of nephrosclerosis by anterior pituitary preparations
NL167691C (en) PROCESS FOR THE PREPARATION OR MANUFACTURE OF THERAPEUTIC PREPARATIONS FOR Soothing and relieving pains of different origins, as well as for treating rheumatic, arthritic and other inflammatory diseases, in which an effective chemical agent is used. IMIDAZOLE COMPOUNDS AND THE PHARMACEUTICALLY ACCEPTABLE ADDITION SALTS THEREOF, SUITABLE FOR APPLICATION IN THIS PROCESS.
Wada et al. Role of relaxin in stimulating mammary gland growth in mice.
JPS5562013A (en) Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent
ROSEMBERG et al. Studies related to the presence of a gonadotropin-inhibiting material in human urine
Hussein et al. Effect of CIDR application duration (7-10-14 days) on circulating estrogen and progesterone during breeding and non-breeding season in she-camels.
US2150131A (en) Hay fever antigen
SE7607630L (en) ASSOCIATION FOR THE TREATMENT OF BOVIN MASTIT
Axelrod et al. Effect of nicotinic acid deficiency on the cozymase content of tissues
US2364760A (en) Therapeutic preparation effective against ulcers
US2541676A (en) Thromboplastic preparation
Suzuki Relation between the Short= timed Peroxidase Reaction of Mouse Leucocytes and the Toxicity of Urine from Mothers with Different Arakawa's Reaction 82nd Report of the Peroxidase Reaction
ES232424A1 (en) A procedure for obtaining an active stimulating breathing material for therapeutic purposes (Machine-translation by Google Translate, not legally binding)
GB1001314A (en) Pharmaceutical preparations for combating parasitic helminths
Debeljuk Lack of gonadotrophin-inhibiting activity of ovine pineal extracts
GB682048A (en) Preparation of a substance for the treatment of malignant tumours
GB734086A (en) Process for the manufacture of therapeutically active substances
ES262765A1 (en) Procedure for the preparation of orthophosphates-21 of steroid and of its hydrosoluble salts physiologically compatible (Machine-translation by Google Translate, not legally binding)
Freed Diethylstilbestrol in Aqueous Suspension
GB938241A (en) Pineal gland extracts
Jones et al. A comparison of calcium dependent contraction in glycerinated uterine smooth muscle and cardiac muscle
Bing Growth-inhibiting properties of steroids